Advaxis (ADXS) Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca's (AZN) IMFINZI

Article Related Press Releases (1) Related Articles (2) Stock Quotes (2)

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. GOOGL

6. APGE
7. USO
8. IBM
9. HOOD
10. ABBV

Top News Most Read Special Reports

Go back to Advaxis (ADXS) Announces Clinical Hold in Axalimogene Filolisbac Phase 1/2 Combination Study with AstraZeneca's (AZN) IMFINZI

Advaxis (ADXS) to Resume Trading at 4:34 pm ET

March 12, 2018 4:10 PM EDT

Advaxis (NASDAQ: ADXS) to Resume Trading at 4:34 pm ET

... More

Advaxis (ADXS) Halted, News Pending

March 12, 2018 4:00 PM EDT

Advaxis (NASDAQ: ADXS) Halted, News Pending

... More